The global Abaca Pulp Market is witnessing rapid growth, fueled by increasing demand in specialty paper, packaging, and industrial applications. Valued at USD 449.56 million in 2023, the market is projected to reach USD 1.42 billion by 2032, registering a CAGR of 13.7% during the forecast period. Abaca pulp, derived from the fibers of the abaca plant (Musa...

The global feed mixer market, valued at USD 820.50 million in 2024, is projected to reach USD 1.16 billion by 2034, expanding at a compound annual growth rate (CAGR) of 3.55% during the forecast period (2025–2034). Growing livestock populations, rising demand for animal protein, and the need for efficient and consistent feed preparation are fueling market growth...

Market Overview The U.S. companion diagnostics (CDx) development market was valued at USD 412.84 million in 2024 and is anticipated to register a CAGR of 7.8% from 2025 to 2034.  The U.S. is a global leader in CDx development due to advanced healthcare infrastructure, a strong biopharmaceutical ecosystem, and supportive regulatory frameworks. Rising investments in oncology research,...

Market Overview NGS library preparation is a critical step in the sequencing workflow, involving the conversion of DNA or RNA samples into a format suitable for sequencing. This process includes fragmentation, end repair, adapter ligation, and amplification, ensuring that the resulting libraries are of high quality and compatible with sequencing platforms. The U.S. next-generation sequencing...

The global superconducting wire market size was estimated at USD 1.14 billion in 2023 and is estimated to grow at a CAGR of 9.0% from 2024 to 2030. Superconducting wire offers superior conduction of electricity with minimal losses making it a popular wire material for energy generation and critical applications. The growing demand for efficient power transmission is anticipated to...

Market Overview The U.S. Tremfya market size was valued at USD 3.18 billion in 2024 and is anticipated to register a CAGR of 5.5% from 2025 to 2034. Rising awareness of biologic therapies, increasing healthcare expenditure, and a shift from conventional treatments to targeted immunotherapies are fueling market expansion. Tremfya is also gaining traction due to its favorable safety profile,...